Literature DB >> 11093683

Morphological patterns of death by myocytes in arrhythmogenic right ventricular dysplasia.

M S Runge1, G A Stouffer, R G Sheahan, S Yamamoto, V G Tsyplenkova, T N James.   

Abstract

There are two forms of nuclear loss from eukaryotic cells: biochemical DNA degradation in apoptosis and nuclear extrusion from the cell body as seen in mammalian erythroblasts. In biopsies of right ventricular myocardium from 8 patients with arrhythmogenic right ventricular dysplasia (ARVD), we found not only a terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine triphosphate nick-end labeling (TUNEL)-positive nucleus in mononuclear myocytes, but also 1 or 2 TUNEL-positive nuclei in multinuclear myocytes. With electron microscopy, we found a nuclear dislocation to the cell periphery, followed by its extrusion into the extracellular space. Both the migration and extrusion of the nuclei of myocytes resemble the morphogenesis of human erythroblasts. Nuclear extrusion from myocytes may be another form of programmed cell death. In support of this possibility, we also found evidence of cytoplasmic degradation in right ventricular myocytes from our ARVD cases, a process similar to one often seen in developmental programmed cell death and differing from typical nuclear apoptosis. In our ARVD cases, we thus found several different patterns of cell death, all associated with initial preservation of the plasmalemma and avoidance of local inflammation. All these features may be different responses to common signals for selective non-necrotic (apoptotic) death of right ventricular myocytes.

Entities:  

Mesh:

Year:  2000        PMID: 11093683     DOI: 10.1097/00000441-200011000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Pharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle Maintenance.

Authors:  Matthew E Randolph; Brittany L Phillips; Hyo-Jung Choo; Katherine E Vest; Yandery Vera; Grace K Pavlath
Journal:  Stem Cells       Date:  2015-12       Impact factor: 6.277

Review 2.  Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Maithili V N Dokuparti; Pranathi Rao Pamuru; Bhavesh Thakkar; Reena R Tanjore; Pratibha Nallari
Journal:  J Hum Genet       Date:  2005-08-12       Impact factor: 3.172

3.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Eduardo Garcia-Gras; Raffaella Lombardi; Michael J Giocondo; James T Willerson; Michael D Schneider; Dirar S Khoury; Ali J Marian
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 4.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

5.  Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.

Authors:  Stephen P Chelko; Gizem Keceli; Andrea Carpi; Nunzianna Doti; Jacopo Agrimi; Angeliki Asimaki; Carlos Bueno Beti; Matthew Miyamoto; Nuria Amat-Codina; Djahida Bedja; An-Chi Wei; Brittney Murray; Crystal Tichnell; Chulan Kwon; Hugh Calkins; Cynthia A James; Brian O'Rourke; Marc K Halushka; Edon Melloni; Jeffrey E Saffitz; Daniel P Judge; Menotti Ruvo; Richard N Kitsis; Peter Andersen; Fabio Di Lisa; Nazareno Paolocci
Journal:  Sci Transl Med       Date:  2021-02-17       Impact factor: 17.956

6.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Julia H Indik; Frank I Marcus
Journal:  Indian Pacing Electrophysiol J       Date:  2003-07-01

7.  Tissue-resident Sca1+ PDGFRα+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy.

Authors:  Ben Paylor; Justin Fernandes; Bruce McManus; Fabio Rossi
Journal:  F1000Res       Date:  2013-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.